Arkolith/Insider Trading/CTXR

CTXR Insider Trading

Citius Pharmaceuticals, Inc. · full profile →Last filing Aug 8, 2025
Mixed · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$0
open market, 180d
Reporting Insiders
0
0 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

100 shown
DateInsiderRoleActionSharesPriceValue
Aug 8, 2025Holubiak Myron ZVice Chairman, DirectorGrant(A)22K——
Aug 8, 2025Holubiak Myron ZVice Chairman, DirectorGrant(A)31K——
Aug 8, 2025Holubiak Myron ZVice Chairman, DirectorDisposed to issuer(D)31K——
Aug 8, 2025Holubiak Myron ZVice Chairman, DirectorDisposed to issuer(D)22K——
Aug 8, 2025Mazur Leonard LChief Executive Officer, DirectorGrant(A)125K——
Aug 8, 2025Mazur Leonard LChief Executive Officer, DirectorDisposed to issuer(D)89K——
Aug 8, 2025Mazur Leonard LChief Executive Officer, DirectorGrant(A)89K——
Aug 8, 2025Mazur Leonard LChief Executive Officer, DirectorDisposed to issuer(D)125K——
Nov 7, 2024Holuka Eugene MyronDirectorGrant(A)125K—$0
Nov 7, 2024Holubiak Myron ZVice Chairman, DirectorGrant(A)350K—$0
Nov 7, 2024Holubiak Myron ZVice Chairman, DirectorGrant(A)75K—$0
Nov 7, 2024McGrath Dennis MDirectorGrant(A)125K—$0
Nov 7, 2024Dutia Suren GDirectorGrant(A)125K—$0
Nov 7, 2024Czuczman MyronChief Medical OfficerGrant(A)300K—$0
Nov 7, 2024Mazur Leonard LChief Executive Officer, Director, 10% OwnerGrant(A)600K—$0
Nov 7, 2024Bartushak JaimeChief Financial OfficerGrant(A)350K—$0
Nov 7, 2024Smith Robert JosephDirectorGrant(A)125K—$0
Nov 7, 2024Webb CarolDirectorGrant(A)125K—$0
Sep 25, 2024Mazur Leonard LChief Executive Officer, Director, 10% OwnerDisposed to issuer(D)2.2M——
Sep 25, 2024Mazur Leonard LChief Executive Officer, Director, 10% OwnerGrant(A)2.2M——
Sep 25, 2024Holubiak Myron ZVice Chairman, DirectorGrant(A)559K——
Sep 25, 2024Holubiak Myron ZVice Chairman, DirectorDisposed to issuer(D)559K——
Aug 14, 2024Mazur Leonard LChief Executive Officer, Director, 10% OwnerDisposed to issuer(D)3.1M——
Aug 14, 2024Mazur Leonard LChief Executive Officer, Director, 10% OwnerGrant(A)3.1M——
Aug 14, 2024Holubiak Myron ZVice Chairman, DirectorGrant(A)784K——
Aug 14, 2024Holubiak Myron ZVice Chairman, DirectorDisposed to issuer(D)784K——
Apr 3, 2024Mazur Leonard LChief Executive Officer, Director, 10% OwnerDisposed to issuer(D)1.2M——
Apr 3, 2024Mazur Leonard LChief Executive Officer, Director, 10% OwnerGrant(A)1.2M——
Apr 3, 2024Holubiak Myron ZVice Chairman, DirectorGrant(A)129K——
Apr 3, 2024Holubiak Myron ZVice Chairman, DirectorDisposed to issuer(D)129K——
Mar 14, 2024Smith Robert JosephDirectorGrant(A)75K—$0
Mar 13, 2024Holuka Eugene MyronDirectorOption exercise(M)2K$0.02$48
Mar 13, 2024Holuka Eugene MyronDirectorTax withholding(F)48$0.75$36
Mar 13, 2024Holuka Eugene MyronDirectorOption exercise(M)2K—$0
Mar 4, 2024Webb CarolDirectorOption exercise(M)12K$0.02$241
Mar 4, 2024Webb CarolDirectorTax withholding(F)236$0.77$182
Mar 4, 2024Webb CarolDirectorOption exercise(M)12K—$0
Oct 10, 2023Mazur Leonard LChief Executive Officer, Director, 10% OwnerGrant(A)550K—$0
Oct 10, 2023McGrath Dennis MDirectorGrant(A)75K—$0
Oct 10, 2023Bartushak JaimeChief Financial OfficerGrant(A)300K—$0
Oct 10, 2023Dutia Suren GDirectorGrant(A)75K—$0
Oct 10, 2023Holuka Eugene MyronDirectorGrant(A)75K—$0
Oct 10, 2023Holubiak Myron ZVice Chairman, DirectorGrant(A)400K—$0
Oct 10, 2023Czuczman MyronChief Medical OfficerGrant(A)300K—$0
Oct 10, 2023Webb CarolDirectorGrant(A)75K—$0
Feb 7, 2023McGrath Dennis MDirectorGrant(A)75K—$0
Oct 4, 2022Czuczman MyronChief Medical OfficerGrant(A)300K—$0
Oct 4, 2022Webb CarolDirectorGrant(A)75K—$0
Oct 4, 2022Holuka Eugene MyronDirectorGrant(A)75K—$0
Oct 4, 2022Safir HowardDirectorGrant(A)75K—$0
Oct 4, 2022Bartushak JaimeChief Financial OfficerGrant(A)300K—$0
Oct 4, 2022Mazur Leonard LExecutive Chairman, Director, 10% OwnerGrant(A)550K—$0
Oct 4, 2022Holubiak Myron ZVice Chairman, DirectorGrant(A)400K—$0
Oct 4, 2022Dutia Suren GDirectorGrant(A)75K—$0
Oct 4, 2022Kane WilliamDirectorGrant(A)75K—$0
Oct 11, 2021Kane WilliamDirectorGrant(A)75K—$0
Oct 11, 2021Czuczman MyronChief Medical OfficerGrant(A)300K—$0
Oct 11, 2021Safir HowardDirectorGrant(A)75K—$0
Oct 11, 2021Holuka Eugene MyronDirectorGrant(A)75K—$0
Oct 11, 2021Webb CarolDirectorGrant(A)75K—$0
Oct 11, 2021Dutia Suren GDirectorGrant(A)75K—$0
Oct 11, 2021Bartushak JaimeChief Financial OfficerGrant(A)300K—$0
Oct 11, 2021Mazur Leonard LExecutive Chairman, Director, 10% OwnerGrant(A)650K—$0
Oct 11, 2021Holubiak Myron ZPresident and CEO, DirectorGrant(A)15K—$0
Oct 11, 2021Holubiak Myron ZPresident and CEO, DirectorGrant(A)650K—$0
Jul 22, 2021Webb CarolDirectorGrant(A)15K—$0
Jul 22, 2021Holuka Eugene MyronDirectorGrant(A)15K—$0
Jul 22, 2021Safir HowardDirectorGrant(A)15K—$0
Jul 22, 2021Bartushak JaimeChief Financial OfficerGrant(A)100K—$0
Jul 22, 2021Mazur Leonard LExecutive Chairman, Director, 10% OwnerGrant(A)300K—$0
Jul 22, 2021Holubiak Myron ZPresident and CEO, Director, 10% OwnerGrant(A)300K—$0
Jul 22, 2021Holubiak Myron ZPresident and CEO, Director, 10% OwnerGrant(A)10K—$0
Jul 22, 2021Dutia Suren GDirectorGrant(A)15K—$0
Jul 22, 2021Kane WilliamDirectorGrant(A)15K—$0
Feb 16, 2021Webb CarolDirectorGrant(A)25K—$0
Feb 16, 2021Holuka Eugene MyronDirectorGrant(A)25K—$0
Feb 16, 2021Safir HowardDirectorGrant(A)25K—$0
Feb 16, 2021Dutia Suren GDirectorGrant(A)25K—$0
Feb 16, 2021Kane WilliamDirectorGrant(A)25K—$0
Oct 6, 2020Webb CarolDirectorGrant(A)35K—$0
Oct 6, 2020Holuka Eugene MyronDirectorGrant(A)35K—$0
Oct 6, 2020Safir HowardDirectorGrant(A)35K—$0
Oct 6, 2020Bartushak JaimeChief Financial OfficerGrant(A)125K—$0
Oct 6, 2020Mazur Leonard LExecutive Chairman, Director, 10% OwnerGrant(A)200K—$0
Oct 6, 2020Holubiak Myron ZPresident and CEO, Director, 10% OwnerGrant(A)200K—$0
Oct 6, 2020Dutia Suren GDirectorGrant(A)35K—$0
Oct 6, 2020Kane WilliamDirectorGrant(A)35K—$0
Jul 14, 2020Czuczman MyronChief Medical OfficerGrant(A)500K—$0
Jul 7, 2020Safir HowardDirectorGrant(A)25K—$0
Jul 7, 2020Dutia Suren GDirectorGrant(A)25K—$0
Jul 7, 2020Kane WilliamDirectorGrant(A)25K—$0
Jul 7, 2020Holuka Eugene MyronDirectorGrant(A)25K—$0
Jul 7, 2020Webb CarolDirectorGrant(A)25K—$0
Oct 8, 2019Bartushak JaimeChief Financial OfficerGrant(A)100K—$0
Oct 8, 2019Dutia Suren GDirectorGrant(A)25K—$0
Oct 8, 2019Holubiak Myron ZPresident and CEO, Director, 10% OwnerGrant(A)175K—$0
Oct 8, 2019Holuka Eugene MyronDirectorGrant(A)25K—$0
Oct 8, 2019Kane WilliamDirectorGrant(A)25K—$0
Oct 8, 2019Mazur Leonard LExecutive Chairman, Director, 10% OwnerGrant(A)175K—$0
Oct 8, 2019Safir HowardDirectorGrant(A)25K—$0

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Issuer: Citius Pharmaceuticals, Inc., SEC CIK 0001506251. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under CTXR and shows every filing by that issuer.

Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).

Keep exploring

Connected pages for CTXR